- Home
- USAU vs LSB Comparison
USAU vs LSB Comparison
Compare USAU & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAU
- LSB
- Stock Information
- Founded
- USAU N/A
- LSB 2002
- Country
- USAU United States
- LSB China
- Employees
- USAU N/A
- LSB N/A
- Industry
- USAU Precious Metals
- LSB
- Sector
- USAU Basic Materials
- LSB
- Exchange
- USAU Nasdaq
- LSB NYSE
- Market Cap
- USAU 68.1M
- LSB 71.2M
- IPO Year
- USAU N/A
- LSB N/A
- Fundamental
- Price
- USAU $6.72
- LSB $2.72
- Analyst Decision
- USAU Strong Buy
- LSB
- Analyst Count
- USAU 2
- LSB 0
- Target Price
- USAU $11.50
- LSB N/A
- AVG Volume (30 Days)
- USAU 129.2K
- LSB 29.0K
- Earning Date
- USAU 12-16-2024
- LSB 12-19-2024
- Dividend Yield
- USAU N/A
- LSB N/A
- EPS Growth
- USAU N/A
- LSB N/A
- EPS
- USAU N/A
- LSB N/A
- Revenue
- USAU N/A
- LSB $79,415,311.00
- Revenue This Year
- USAU N/A
- LSB $39.33
- Revenue Next Year
- USAU N/A
- LSB $75.61
- P/E Ratio
- USAU N/A
- LSB N/A
- Revenue Growth
- USAU N/A
- LSB N/A
- 52 Week Low
- USAU $3.20
- LSB $1.88
- 52 Week High
- USAU $8.62
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- USAU 51.58
- LSB 46.21
- Support Level
- USAU $5.86
- LSB $2.21
- Resistance Level
- USAU $7.30
- LSB $3.83
- Average True Range (ATR)
- USAU 0.32
- LSB 0.40
- MACD
- USAU 0.10
- LSB -0.10
- Stochastic Oscillator
- USAU 59.72
- LSB 31.54
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.